Intro Whether intestinal dysmotility and proton pump inhibitor (PPI) use either independently or collectively contributes to small intestinal bacterial overgrowth (SIBO) and/or small intestinal fungal overgrowth (SIFO) is not known. phasic activity impaired antro-duodenal coordination. Bacterial growth ≥103 CFU/mL or fungal growth was considered evidence for SIBO/SIFO. PPI use was documented. Correlation of symptoms with… Continue reading Intro Whether intestinal dysmotility and proton pump inhibitor (PPI) use either